GENERALIZED TONIC CLONIC SEIZURE

Clinical trials for GENERALIZED TONIC CLONIC SEIZURE explained in plain language.

Never miss a new study

Get alerted when new GENERALIZED TONIC CLONIC SEIZURE trials appear

Sign up with your email to follow new studies for GENERALIZED TONIC CLONIC SEIZURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for controlling devastating seizures in rare genetic disorder

Disease control Ongoing

This study is testing whether adding the medication ZX008 (fenfluramine) to existing treatments can better control seizures in people with CDKL5 deficiency disorder, a rare genetic condition that causes severe epilepsy and developmental delays. The trial involves children and adu…

Matched conditions: GENERALIZED TONIC CLONIC SEIZURE

Phase: PHASE3 • Sponsor: Zogenix, Inc. • Aim: Disease control

Last updated Apr 02, 2026 09:57 UTC

GENERALIZED TONIC CLONIC SEIZURE

Get alerted when new GENERALIZED TONIC CLONIC SEIZURE trials appear

New hope for controlling devastating seizures in rare genetic disorder